Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

377 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The COVID-19 Vaccine Landscape.
Koch T, Fathi A, Addo MM. Koch T, et al. Among authors: fathi a. Adv Exp Med Biol. 2021;1318:549-573. doi: 10.1007/978-3-030-63761-3_31. Adv Exp Med Biol. 2021. PMID: 33973199 Review.
Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, Dahlke C, Kobbe R, Santer R, Koch T, Fathi A, Seco BMS, Ly ML, Schmiedel S, Schwinge D, Serna S, Sellrie K, Reichardt NC, Seeberger PH, Addo MM, Loeffler FF, On Behalf Of The Id-Uke Covid-Study Group. Heidepriem J, et al. Among authors: fathi a. Pathogens. 2021 Apr 6;10(4):438. doi: 10.3390/pathogens10040438. Pathogens. 2021. PMID: 33917609 Free PMC article.
Multi-Site 11-Year Experience of Less-Intensive versus Intensive Therapies in Acute Myeloid Leukemia.
Sorror ML, Storer BE, Fathi AT, Brunner AM, Gerds AT, Sekeres MA, Mukherjee S, Medeiros BC, Wang ES, Vachhani P, Shami PJ, Peña E, Elsawy M, Adekola KUA, Luger S, Baer MR, Rizzieri D, Wildes T, Koprivnikar J, Smith J, Garrison M, Kojouri K, Leisenring WM, Onstad L, Nyland JE, Becker PS, McCune JS, Lee SJ, Sandmaier BM, Appelbaum F, Estey EH. Sorror ML, et al. Among authors: fathi at. Blood. 2021 Apr 28:blood.2020008812. doi: 10.1182/blood.2020008812. Online ahead of print. Blood. 2021. PMID: 33910230
A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML.
Mason EF, Pozdnyakova O, Roshal M, Fathi AT, Stein EM, Ferrell PB, Shaver AC, Frattini M, Wang H, Hua L, Mu J, Choe S, Xu R, Almon C, Cooper M, Stone RM, Hasserjian RP, Savona MR. Mason EF, et al. Among authors: fathi at. Blood Adv. 2021 Apr 27;5(8):2279-2283. doi: 10.1182/bloodadvances.2020003685. Blood Adv. 2021. PMID: 33904894 Free PMC article. No abstract available.
Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Chen EC, Li S, Eisfeld AK, Luskin MR, Mims A, Jones D, Antin JH, Cutler CS, Koreth J, Ho VT, Gooptu M, Romee R, El-Jawahri A, McAfee SL, DeFilipp Z, Soiffer RJ, Chen YB, Fathi AT. Chen EC, et al. Among authors: fathi at. Transplant Cell Ther. 2021 Feb 25:S2666-6367(21)00715-6. doi: 10.1016/j.jtct.2021.02.028. Online ahead of print. Transplant Cell Ther. 2021. PMID: 33840625
377 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page